A new empirical definition of major depressive episode recovery and its positive impact on future course of illness

Journal of Clinical Psychiatry

Volumn 77, Issue 8, 2016, Pages 1065-1073

  Judd, Lewis L ^a   Schettler, Pamela J ^a   Rush, A John ^b   Coryell, William H ^c   Fiedorowicz, Jess G ^c,d   Solomon, David A ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SOCIAL PSYCHOLOGY; SURVIVAL ANALYSIS; VALIDITY; CONSENSUS; DEPRESSIVE DISORDER, MAJOR; LONGITUDINAL STUDY; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; REMISSION; REPRODUCIBILITY; STANDARDS; UNITED STATES;

ADULT; AGED; CONSENSUS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); OUTCOME ASSESSMENT (HEALTH CARE); RECURRENCE; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 84989328974     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m09918     Document Type: Article

References (46)

1. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851-855. doi:10.101/archpsyc.191.01810307501 PubMed.
2. Rush AJ, Kraemer HC, Sackeim HA, et al; ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31(9):1841-1853. doi:10.1038/sj.np.130131 PubMed.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing; 2013.
4. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: A focus on treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):5-9. PubMed.
5. Judd LL, Paulus MP, Wells KB, et al. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry. 1996;153(11):1411-1417. doi:10.176/ajp.153.1.141 PubMed.
6. Akiskal HS, Judd LL, Gillin JC, et al. Subthreshold depressions: clinical and polysomnographic validation of dysthymic, residual and masked forms. J Affect Disord. 1997;45(1-2):53-63. doi:10.1016/S0165-0327(97)059-1 PubMed.
7. Judd LL. Pleomorphic expressions of unipolar depressive disease: summary of the 1996 CINP President's Workshop. J Affect Disord. 1997;45(1-2):109-116. doi:10.1016/S0165-0327(97)064-5 PubMed.
8. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord. 1997;45(1-2):5-17, discussion 17-18. doi:10.1016/S0165-0327(97)05-4 PubMed.
9. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55(8):694-700. doi:10.101/archpsyc.5.8.694 PubMed.
10. Judd LL, Akiskal HS. Delineating the longitudinal structure of depressive illness: Beyond clinical subtypes and duration thresholds. Pharmacopsychiatry. 2000;33(1):3-7. doi:10.105/s-20-7967 PubMed.
11. Judd LL, Akiskal HS, Zeller PJ, et al. Psychosocial disability during the long-Term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57(4):375-380. doi:10.101/archpsyc.57.4.375 PubMed.
12. Judd LL. Dimensional paradigm of the longterm course of unipolar major depressive disorder. Depress Anxiety. 2012;29(3):167-171. doi:10.102/da.21934 PubMed.
13. Judd LL, Schettler PJ, Akiskal HS, et al. Dimensional symptomatic structure of the long-Term course of unipolar major depressive disorder. In: Keller MB, Coryell WH, Endicott J, et al, eds. Clinical Guide to Depression and Bipolar Disorder: Findings From the Collaborative Depression Study, Chapter 3. Washington, DC: American Psychiatric Publishing; 2013.
14. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998;50(2-3):97-108. doi:10.1016/S0165-0327(98)0138-4 PubMed.
15. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9):1501-1504. doi:10.176/api.ajp.157.9.1501 PubMed.
16. Katz MM, Klerman GL. Introduction: overview of the clinical studies program. Am J Psychiatry. 1979;136(1):49-51. doi:10.176/ajp.136.1.49 PubMed.
17. Katz MM, Secunda SK, Hirschfeld RM, et al. NIMH clinical research branch collaborative program on the psychobiology of depression. Arch Gen Psychiatry. 1979;36(7):765-771. doi:10.101/archpsyc.1979.01780704304 PubMed.
18. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: Rationale and reliability. Arch Gen Psychiatry. 1978;35(6):773-782. doi:10.101/archpsyc.1978.01703015013 PubMed.
19. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS). 3rd ed. New York, NY: New York State Psychiatric Institute, Biometrics Research Division; 1979.
20. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation: A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548. doi:10.101/archpsyc.1987.0180180509 PubMed.
21. Keller MB, Shapiro RW. Major depressive disorder: initial results from a one-year prospective naturalistic follow-up study. J Nerv Ment Dis. 1981;169(12):761-768. doi:10.1097/05053-198120-03 PubMed.
22. Cox DR, Oakes D. Analysis of Survival Data. London, UK: Chapman and Hall; 1984.
23. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
24. Lavori PW, Keller MB, Mueller TI, et al. Recurrence after recovery in unipolar MDD: An observational follow-up study of clinical predictors and somatic treatment as a mediating factor. Int J Methods Psychiatr Res. 1994;4:211-229.
25. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766-771. doi:10.101/archpsyc.1976.01706086012 PubMed.
26. Guilford JP, Zimmerman WS. The Guilford- Zimmerman Temperament Survey Manual. Beverly Hills, CA: Sheridan Supply Co; 1949.
27. Hathaway SR, McKinley JC. The Minnesota Multiphasic Personality Inventory, Revised. New York, NY: Psychological Corp.; 1951.
28. Cleare A, Pariante CM, Young AH, et al; Members of the Consensus Meeting. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459-525. doi:10.17/026981581093 PubMed.
29. Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: The role of long-Term pharmacotherapy and psychotherapy. J Clin Psychiatry. 2003;64(suppl 15):13-17. PubMed.
30. Nierenberg AA, Husain MM, Trivedi MH, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: A STAR∗D report. Psychol Med. 2010;40(1):41-50. doi:10.1017/S032917090601 PubMed.
31. Kurian BT, Greer TL, Trivedi MH. Strategies to enhance the therapeutic efficacy of antidepressants: Targeting residual symptoms. Expert Rev Neurother. 2009;9(7):975-984. doi:10.1586/ern.09.53 PubMed.
32. Zajecka JM. Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances. J Clin Psychiatry. 2013;74(suppl 2):9-13. doi:10.408/JCP.12084su1c.02 PubMed.
33. Shelton RC, Tomarken AJ. Can recovery from depression be achieved? Psychiatr Serv. 2001;52(11):1469-1478. doi:10.176/api.ps.52.1.1469 PubMed.
34. Trivedi MH, Hollander E, Nutt D, et al. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry. 2008;69(2):246-258. doi:10.408/JCP.v69n021 PubMed.
35. Blier P. Neurotransmitter targeting in the treatment of depression. J Clin Psychiatry. 2013;74(suppl 2):19-24. doi:10.408/JCP.12084su1c.04 PubMed.
36. Richelson E. Multi-modality: A new approach for the treatment of major depressive disorder. Int J Neuropsychopharmacol. 2013;16(06):1433-1442. doi:10.1017/S14614571201605.
37. Fava M, Ball S, Nelson JC, et al. Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety. 2014;31(3):250-257. doi:10.102/da.219 PubMed.
38. Papakostas GI. Major depressive disorder: psychosocial impairment and key considerations in functional improvement. Am J Manag Care. 2009;15(suppl):S316-S321. PubMed.
39. Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs. 2010;24(4):267-284. doi:10.2165/1530230-0-0PubMed.
40. Serretti A, Chiesa A, Souery D, et al. Social adjustment among treatment responder patients with mood disorders. J Affect Disord. 2013;150(3):961-966. doi:10.1016/j.jad.2013.05.021 PubMed.
41. Fried EI, Nesse RM. The impact of individual depressive symptoms on impairment of psychosocial functioning. PLoS ONE. 2014;9(2):e90311. doi:10.1371/journal.pone.09031 PubMed.
42. Spijker J, de Graaf, R, Oldehinkel AJ, et al. Are the vulnerability effects of personality and psychosocial functioning on depression accounted for by subthreshold symptoms? Depress Anxiety. 2007;24(7):472-478. doi:10.102/da.20252 PubMed.
43. Mulder RT. Personality pathology and treatment outcome in major depression: A review. Am J Psychiatry. 2002;159(3):359-371. doi:10.176/api.ajp.159.3.359 PubMed.
44. Mulder RT, Frampton CM, Luty SE, et al. Eighteen months of drug treatment for depression: predicting relapse and recovery. J Affect Disord. 2009;114(1-3):263-270. doi:10.1016/j.jad.208.08.02 PubMed.
45. Hirschfeld RM, Dunner DL, Keitner G, et al. Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry. 2002;51(2):123-133. doi:10.1016/S06-323(01)01291-4 PubMed.
46. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care, Volume 2. Treatment of Major Depression. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, AHCPR Publication No. 93-0551;1993:1.